Amgen (AMGN) Total Current Liabilities (2009 - 2026)

Amgen (AMGN) has reported Total Current Liabilities for 18 consecutive years, with $25.0 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Total Current Liabilities rose 8.46% year-over-year to $25.0 billion; the TTM figure through Mar 2026 stood at $25.0 billion (up 8.46% YoY), while the FY2025 annual figure was $25.5 billion, up 10.35% from the prior year.
• Total Current Liabilities came in at $25.0 billion for Q1 2026 at Amgen, down from $25.5 billion in the prior quarter.
• The five-year high for Total Current Liabilities was $25.5 billion in Q4 2025, with the low at $12.6 billion in Q2 2022.
• Average Total Current Liabilities over 5 years is $19.0 billion, with a median of $19.7 billion recorded in 2024.
• Across the five-year window, Total Current Liabilities slipped 13.49% in 2022 and surged 38.68% in 2024, its largest moves.
• Year by year, Total Current Liabilities stood at $15.7 billion in 2022, then climbed by 17.24% to $18.4 billion in 2023, then advanced by 25.59% to $23.1 billion in 2024, then gained by 10.35% to $25.5 billion in 2025, then retreated by 2.1% to $25.0 billion in 2026.
• According to Business Quant data, Total Current Liabilities over the past three periods registered $25.0 billion, $25.5 billion, and $21.8 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.